Vaziri N D, Goldman R, Schultze R G, Lee D B, Rosen S M
West J Med. 1977 Feb;126(2):91-4.
Maintenance hemodialysis and chemotherapeutic agents were used in the treatment of seven patients with end-stage myeloma kidney disease. Results indicate that with the use of such therapy life can be prolonged substantially. It appears that patients with myeloma-with or without serious extrarenal complications-are suitable candidates for maintenance hemodialysis and should not be denied the treatment even in the face of systemic neoplasm.
维持性血液透析和化疗药物被用于治疗7例终末期骨髓瘤肾病患者。结果表明，采用这种治疗方法可显著延长生命。看来，无论有无严重肾外并发症的骨髓瘤患者，都是维持性血液透析的合适人选，即使面对全身性肿瘤，也不应拒绝给予这种治疗。
